About Sol-gel (SLGL)
Sol-Gel Technologies Ltd operates as a clinical stage pharmaceutical company. The Company identifies and develops topical dermatological drug products for the treatment of skin diseases. Sol-Gel Technologies markets its products worldwide.
- USD59.20
- USD65.00
- USD58.47
- 61.74k
Stock News
yesterday
U.S. stock futures fall, along with bitcoin and oil prices
MarketWatch
yesterday
Forget AI Stocks: This REIT Could Be Your Ticket to AI Profits
Yahoo
yesterday
How this 32-year-old New Yorker turned her love of dogs into a dream career: 'I feel like the luckiest person in the world'
CNBC
yesterday
Speaker Johnson: 'Confident' government shutdown will end by Tuesday
CNBC